Jeremy Graff
Vermögen: 41 087 $ am 31.05.2026
Vermögen: 41 087 $ am 31.05.2026
Jeremy R.
Graff is currently Chairman at IN8bio, Inc. starting in 2026, Trustee at Wood Hudson Cancer Research Laboratory, Inc., and President & Chief Development Officer at Allarity Therapeutics, Inc. beginning in 2024.
Former roles include Chief Scientific Officer at IMV, Inc. from 2021 to 2024, Chief Development Officer & Senior VP-Research at HiberCell, Inc. from 2020 to 2021, and President & Chief Scientific Officer at Biothera Pharmaceuticals, Inc. (Delaware) from 2018 to 2020 as well as at Biothera, Inc. Education includes undergraduate studies at Thomas More University and a doctorate from the University of Kentucky.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.04.2026 | 24’881 ( 0.16% ) | 40 805 $ | 31.05.2026 | |
| 09.05.2026 | 151 ( 0% ) | 282 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IN8BIO, INC. | Vorsitzender | 28.02.2026 |
| ALLARITY THERAPEUTICS, INC. | Präsident | 03.10.2024 |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| IMV INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Präsident | 01.06.2020 |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Präsident | 01.06.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Thomas More University
Thomas More University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Commercial Services |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen